Literature DB >> 28898712

Inhibition of the lytic cycle of Kaposi's sarcoma-associated herpesvirus by cohesin factors following de novo infection.

Zsolt Toth1, Richard J Smindak2, Bernadett Papp3.   

Abstract

Establishment of Kaposi's sarcoma-associated herpesvirus (KSHV) latency following infection is a multistep process, during which polycomb proteins are recruited onto the KSHV genome, which is crucial for the genome-wide repression of lytic genes during latency. Strikingly, only a subset of lytic genes are expressed transiently in the early phase of infection prior to the binding of polycomb proteins onto the KSHV genome, which raises the question what restricts lytic gene expression in the first hours of infection. Here, we demonstrate that both CTCF and cohesin chromatin organizing factors are rapidly recruited to the viral genome prior to the binding of polycombs during de novo infection, but only cohesin is required for the genome-wide inhibition of lytic genes. We propose that cohesin is required for the establishment of KSHV latency by initiating the repression of lytic genes following infection, which is an essential step in persistent infection of humans.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CTCF; Chromatin; Cohesin; Herpesvirus; KSHV; Lytic gene expression; NIPBL; Polycomb proteins; Viral latency; de novo infection

Mesh:

Substances:

Year:  2017        PMID: 28898712      PMCID: PMC5653454          DOI: 10.1016/j.virol.2017.09.001

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  41 in total

Review 1.  Cornelia de Lange Syndrome and the link between chromosomal function, DNA repair and developmental gene regulation.

Authors:  Tom Strachan
Journal:  Curr Opin Genet Dev       Date:  2005-06       Impact factor: 5.578

Review 2.  Transcriptional regulation by Polycomb group proteins.

Authors:  Luciano Di Croce; Kristian Helin
Journal:  Nat Struct Mol Biol       Date:  2013-10       Impact factor: 15.369

3.  Immunologic features of Cornelia de Lange syndrome.

Authors:  Soma Jyonouchi; Jordan Orange; Kathleen E Sullivan; Ian Krantz; Matthew Deardorff
Journal:  Pediatrics       Date:  2013-07-01       Impact factor: 7.124

4.  Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression.

Authors:  Zsolt Toth; Kevin F Brulois; Lai-Yee Wong; Hye-Ra Lee; Brian Chung; Jae U Jung
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

5.  Influence of ND10 components on epigenetic determinants of early KSHV latency establishment.

Authors:  Thomas Günther; Sabrina Schreiner; Thomas Dobner; Uwe Tessmer; Adam Grundhoff
Journal:  PLoS Pathog       Date:  2014-07-17       Impact factor: 6.823

6.  Increased DNA damage sensitivity of Cornelia de Lange syndrome cells: evidence for impaired recombinational repair.

Authors:  Mischa G Vrouwe; Elhaam Elghalbzouri-Maghrani; Matty Meijers; Peter Schouten; Barbara C Godthelp; Zahurul A Bhuiyan; Egbert J Redeker; Marcel M Mannens; Leon H F Mullenders; Albert Pastink; Firouz Darroudi
Journal:  Hum Mol Genet       Date:  2007-04-27       Impact factor: 6.150

7.  Epigenetic analysis of KSHV latent and lytic genomes.

Authors:  Zsolt Toth; Dennis T Maglinte; Sun Hwa Lee; Hye-Ra Lee; Lai-Yee Wong; Kevin F Brulois; Stacy Lee; Jonathan D Buckley; Peter W Laird; Victor E Marquez; Jae U Jung
Journal:  PLoS Pathog       Date:  2010-07-22       Impact factor: 6.823

8.  Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation.

Authors:  Hyojeung Kang; Andreas Wiedmer; Yan Yuan; Erle Robertson; Paul M Lieberman
Journal:  PLoS Pathog       Date:  2011-08-18       Impact factor: 6.823

9.  The cohesin-associated protein Wapal is required for proper Polycomb-mediated gene silencing.

Authors:  Cary Stelloh; Michael H Reimer; Kirthi Pulakanti; Steven Blinka; Jonathan Peterson; Luca Pinello; Shuang Jia; Sergei Roumiantsev; Martin J Hessner; Samuel Milanovich; Guo-Cheng Yuan; Sridhar Rao
Journal:  Epigenetics Chromatin       Date:  2016-04-15       Impact factor: 4.954

10.  Genome-wide control of RNA polymerase II activity by cohesin.

Authors:  Cheri A Schaaf; Hojoong Kwak; Amanda Koenig; Ziva Misulovin; David W Gohara; Audrey Watson; Yanjiao Zhou; John T Lis; Dale Dorsett
Journal:  PLoS Genet       Date:  2013-03-21       Impact factor: 5.917

View more
  9 in total

1.  Characterization of de novo lytic infection of dermal lymphatic microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus.

Authors:  Gavin Golas; Juan D Alonso; Zsolt Toth
Journal:  Virology       Date:  2019-07-31       Impact factor: 3.616

2.  Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.

Authors:  Bernadett Papp; Naeem Motlagh; Richard J Smindak; Seung Jin Jang; Aria Sharma; Juan D Alonso; Zsolt Toth
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

3.  KSHV RTA Induces Degradation of the Host Transcription Repressor ID2 To Promote the Viral Lytic Cycle.

Authors:  Lauren R Combs; Lauren McKenzie Spires; Juan D Alonso; Bernadett Papp; Zsolt Toth
Journal:  J Virol       Date:  2022-05-23       Impact factor: 6.549

4.  Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.

Authors:  Dajiang Li; Tim Mosbruger; Dinesh Verma; Sankar Swaminathan
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

5.  Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.

Authors:  Nenavath Gopal Naik; Thomas Hong Nguyen; Lauren Roberts; Luke Todd Fischer; Katherine Glickman; Gavin Golas; Bernadett Papp; Zsolt Toth
Journal:  PLoS Pathog       Date:  2020-01-10       Impact factor: 6.823

6.  KSHV Topologically Associating Domains in Latent and Reactivated Viral Chromatin.

Authors:  Mel Campbell; Chanikarn Chantarasrivong; Yuichi Yanagihashi; Tomoki Inagaki; Ryan R Davis; Kazushi Nakano; Ashish Kumar; Clifford G Tepper; Yoshihiro Izumiya
Journal:  J Virol       Date:  2022-07-11       Impact factor: 6.549

7.  PRC1-independent binding and activity of RYBP on the KSHV genome during de novo infection.

Authors:  See-Chi Lee; Zsolt Toth
Journal:  PLoS Pathog       Date:  2022-08-26       Impact factor: 7.464

Review 8.  Regulation of KSHV Latency and Lytic Reactivation.

Authors:  Grant Broussard; Blossom Damania
Journal:  Viruses       Date:  2020-09-17       Impact factor: 5.048

9.  Quantitative Proteomics Analysis of Lytic KSHV Infection in Human Endothelial Cells Reveals Targets of Viral Immune Modulation.

Authors:  Ildar Gabaev; James C Williamson; Thomas W M Crozier; Thomas F Schulz; Paul J Lehner
Journal:  Cell Rep       Date:  2020-10-13       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.